News EyePoint Pharmaceuticals, Inc.

Equities

EYPT

US30233G2093

Real-time Estimate Cboe BZX Other stock markets 10:12:47 2024-04-24 am EDT			5-day change	1st Jan Change
17.42 ^USD	-0.88%		-16.95%	-24.75%

Apr. 02	EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board	CI
Mar. 18	EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) added to S&P Pharmaceuticals Select Industry Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EyePoint Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	Apr. 17	AQ
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	Apr. 16	AQ
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists	Apr. 02	AQ
EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board	Apr. 02	CI
EyePoint Pharmaceuticals : Investor Presentation March 2024	Mar. 22	PU
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	Mar. 18	AQ
EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) added to S&P Pharmaceuticals Select Industry Index	Mar. 17	CI
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	Mar. 07	MT
Transcript : EyePoint Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
EyePoint Pharmaceuticals' Q4 Net Loss Narrows, Revenue Advances; Shares Up Pre-Bell	Mar. 07	MT
Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q4 Revenue $14M	Mar. 07	MT
EyePoint Pharmaceuticals: Q4 Earnings Snapshot	Mar. 07	AQ
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments	Mar. 07	AQ
EyePoint Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
EyePoint Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
North American Morning Briefing : Powell Still in -2-	Mar. 07	DJ
EyePoint Pharmaceuticals Names Ramiro Ribeiro Chief Medical Officer	Mar. 04	MT
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer	Mar. 04	AQ
EyePoint Pharmaceuticals, Inc. Announces Executive Changes	Mar. 04	CI
EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024	Feb. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News EyePoint Pharmaceuticals, Inc.

Equities

EYPT

US30233G2093

Summary

Filters